TY - JOUR
T1 - Role of Polyunsaturated Fat in Modifying Cardiovascular Risk Associated With Family History of Cardiovascular Disease
T2 - Pooled De Novo Results From 15 Observational Studies
AU - Fatty Acids and Outcomes Research Consortium (FORCE)
AU - Laguzzi, Federica
AU - Åkesson, Agneta
AU - Marklund, Matti
AU - Qian, Frank
AU - Gigante, Bruna
AU - Bartz, Traci M.
AU - Bassett, Julie K.
AU - Birukov, Anna
AU - Campos, Hannia
AU - Hirakawa, Yoichiro
AU - Imamura, Fumiaki
AU - Jäger, Susanne
AU - Lankinen, Maria
AU - Murphy, Rachel A.
AU - Senn, MacKenzie
AU - Tanaka, Toshiko
AU - Tintle, Nathan
AU - Virtanen, Jyrki K.
AU - Yamagishi, Kazumasa
AU - Allison, Matthew
AU - Brouwer, Ingeborg A.
AU - De Faire, Ulf
AU - Eiriksdottir, Gudny
AU - Ferrucci, Luigi
AU - Forouhi, Nita G.
AU - Geleijnse, Johanna M.
AU - Hodge, Allison M.
AU - Kimura, Hitomi
AU - Laakso, Markku
AU - Risérus, Ulf
AU - Van Westing, Anniek C.
AU - Bandinelli, Stefania
AU - Baylin, Ana
AU - Giles, Graham G.
AU - Gudnason, Vilmundur
AU - Iso, Hiroyasu
AU - Lemaitre, Rozenn N.
AU - Ninomiya, Toshiharu
AU - Post, Wendy S.
AU - Psaty, Bruce M.
AU - Salonen, Jukka T.
AU - Schulze, Matthias B.
AU - Tsai, Michael Y.
AU - Uusitupa, Matti
AU - Wareham, Nicholas J.
AU - Oh, Seung Won
AU - Wood, Alexis C.
AU - Harris, William S.
AU - Siscovick, David
AU - Mozaffarian, Dariush
N1 - Publisher Copyright:
© 2024 Lippincott Williams and Wilkins. All rights reserved.
PY - 2024/1/23
Y1 - 2024/1/23
N2 - BACKGROUND: It is unknown whether dietary intake of polyunsaturated fatty acids (PUFA) modifies the cardiovascular disease (CVD) risk associated with a family history of CVD. We assessed interactions between biomarkers of low PUFA intake and a family history in relation to long-term CVD risk in a large consortium. METHODS: Blood and tissue PUFA data from 40 885 CVD-free adults were assessed. PUFA levels ≤25th percentile were considered to reflect low intake of linoleic, alpha-linolenic, and eicosapentaenoic/docosahexaenoic acids (EPA/DHA). Family history was defined as having ≥1 first-degree relative who experienced a CVD event. Relative risks with 95% CI of CVD were estimated using Cox regression and meta-analyzed. Interactions were assessed by analyzing product terms and calculating relative excess risk due to interaction. RESULTS: After multivariable adjustments, a significant interaction between low EPA/DHA and family history was observed (product term pooled RR, 1.09 [95% CI, 1.02-1.16]; P=0.01). The pooled relative risk of CVD associated with the combined exposure to low EPA/DHA, and family history was 1.41 (95% CI, 1.30-1.54), whereas it was 1.25 (95% CI, 1.16-1.33) for family history alone and 1.06 (95% CI, 0.98-1.14) for EPA/DHA alone, compared with those with neither exposure. The relative excess risk due to interaction results indicated no interactions. CONCLUSIONS: A significant interaction between biomarkers of low EPA/DHA intake, but not the other PUFA, and a family history was observed. This novel finding might suggest a need to emphasize the benefit of consuming oily fish for individuals with a family history of CVD.
AB - BACKGROUND: It is unknown whether dietary intake of polyunsaturated fatty acids (PUFA) modifies the cardiovascular disease (CVD) risk associated with a family history of CVD. We assessed interactions between biomarkers of low PUFA intake and a family history in relation to long-term CVD risk in a large consortium. METHODS: Blood and tissue PUFA data from 40 885 CVD-free adults were assessed. PUFA levels ≤25th percentile were considered to reflect low intake of linoleic, alpha-linolenic, and eicosapentaenoic/docosahexaenoic acids (EPA/DHA). Family history was defined as having ≥1 first-degree relative who experienced a CVD event. Relative risks with 95% CI of CVD were estimated using Cox regression and meta-analyzed. Interactions were assessed by analyzing product terms and calculating relative excess risk due to interaction. RESULTS: After multivariable adjustments, a significant interaction between low EPA/DHA and family history was observed (product term pooled RR, 1.09 [95% CI, 1.02-1.16]; P=0.01). The pooled relative risk of CVD associated with the combined exposure to low EPA/DHA, and family history was 1.41 (95% CI, 1.30-1.54), whereas it was 1.25 (95% CI, 1.16-1.33) for family history alone and 1.06 (95% CI, 0.98-1.14) for EPA/DHA alone, compared with those with neither exposure. The relative excess risk due to interaction results indicated no interactions. CONCLUSIONS: A significant interaction between biomarkers of low EPA/DHA intake, but not the other PUFA, and a family history was observed. This novel finding might suggest a need to emphasize the benefit of consuming oily fish for individuals with a family history of CVD.
KW - biomarkers
KW - cardiovascular diseases
KW - family medical history
KW - polyunsaturated fatty acids
KW - precision medicine
UR - http://www.scopus.com/inward/record.url?scp=85183312598&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85183312598&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.123.065530
DO - 10.1161/CIRCULATIONAHA.123.065530
M3 - Article
C2 - 38047387
AN - SCOPUS:85183312598
SN - 0009-7322
VL - 149
SP - 305
EP - 316
JO - Circulation
JF - Circulation
IS - 4
ER -